Advertisement

Topics

Latest "boston.com" News Stories

12:40 EST 19th November 2018 | BioPortfolio

Here are the most relevant search results for "boston.com" found in our extensive news archives from over 250 global news sources.

More Information about boston.com on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about boston.com for you to read. Along with our medical data and news we also list boston.com Clinical Trials, which are updated daily. BioPortfolio also has a large database of boston.com Companies for you to search.

Showing "boston" News Articles 1–25 of 1,900+

Monday 19th November 2018

Visible Body Announces Strategic Investment From Capitala Group and Lineage Capital

Private Equity Firms Invest in Maker of World’s Most Popular Human Anatomy Apps Visible Body, creator of the world’s best-selling human anatomy apps, today announced a strategic investment from two private equity firms, Capitala Group and


Boston Children's Hospital Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 13112018] Prices from USD $250

SummaryBoston Children's Hospital Boston Children's is the pediatric medical center that provides a comprehensive range of health care services for children from birth through 21 years of age. Boston Children's is the primary pediatric teaching affiliate of Harvard Medical School. The organization provides specialty services such as cardiovascular surgery, digestive care, blood diseases, fetal car...

Partners HealthCare System Inc Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 13112018] Prices from USD $250

SummaryPartners HealthCare System Inc PHS is a nonprofit integrated healthcare organization. It operates a network of community and specialty hospitals, a physician network, managed care organizations, home health and longterm care centers, community health centers and other healthcare entities. The organization focuses on providing patient care, research, teaching, and other services to patients ...


Steward Health Care System LLC Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 13112018] Prices from USD $250

SummarySteward Health Care System LLC Steward is a communitybased care organization led by physicians, which operates a wide network of forprofit hospitals that provide communitybased healthcare services. It is an integrated organization, which provides comprehensive healthcare services to patients through its hospitals, affiliated urgent care providers, health care network, medical centers, medic...

FLX Bio to Present at Evercore ISI HealthCONx Conference

FLX Bio, Inc., a clinical-stage, biopharmaceutical company focused on the development of oral small-molecule drugs that target immune drivers of cancer and other immune-related disorders, today announced that Brian Wong, M.D., Ph.D., CEO and Rekha Hemrajani, COO will participate in an analyst-led fireside chat at the Evercore ISI HealthCONx on Tuesday, Nov...

Generation Bio to Present at the Evercore ISI Healthcare Conference

Generation Bio, a company developing the first genetic medicines that can be titrated to effect and re-dosed for a lifetime of benefit, today announced that the company will present at the Evercore ISI Healthcare Conference in Boston, MA. President and Chief Executive Officer Geoff McDonough will provide an overview of the company on Wednesday, November ...

Innovus Pharmaceuticals Acquires Worldwide Rights to Four Products from Boston Topicals, LLC

- HealthiFeet®, Among the Products Acquired, Has Been a Proven Category Leader in Pilot Programs in Multiple Retail Stores Innovus Pharmaceuticals, Inc., (“Innovus Pharma”) (OTCQB: INNV), an emerging commercial-stage pharmaceutical company that delivers safe, innovative and effective over-the-counter and consumer care products to improve...

VIDEO: Lundbeck Still Assessing Future Of Antipsychotic After Phase III Failure, Says CEO

Deborah Dunsire, Lundbeck’s new CEO, talks to Scrip about the fallout from its recent Phase III setback, and how she...   

Sunday 18th November 2018

Targeted Hepatitis C testing misses substantial number of cases in correctional setting

(Boston Medical Center) Results from a new study led by Boston Medical Center (BMC) found routine Hepatitis C testing identified a significant number of cases that would have been missed by targeted testing among a population of individuals in Washington State prisons

LogicBio, CMRI partner to develop next-gen viral vectors

LogicBio, a Boston-based genome editing company, has partnered with Children’s Medical Research Institute (CMRI) to fast-track gene therapy treatments for children with life-threatening genetic liver disease. The two will jointly develop next-generation synthetic adeno-associated virus (AAV) capsids capable of overcoming many of the current limitations of existing viral vectors. LogicBio will h...

Methylation and Cell Death—One Key to Preventing Autoimmunity

Researchers at Dana-Farber Cancer Institute (DFCI; Boston) and Harvard Medical School (HMS; Boston) have identified a mechanism the immune system uses to detect and eliminate dysfunctional T-cells...

Paratek Pharmaceuticals Inc PRTK Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 09112018] Prices from USD $250

SummaryParatek Pharmaceuticals Inc Paratek is a biopharmaceutical company that develops and commercializes therapies based on tetracycline chemistry. Omadacycline antibiotic, the company's lead product candidate is an aminomethylcycline which acts against gramnegative, grampositive, and atypical bacteria. It is investigating omadacycline in Phase III for the treatment of infections resistant to an...

Saturday 17th November 2018

Week in Review: CStone Pharma, a Suzhou Oncology Company, Files for Hong Kong IPO

Deals and Financings  Suzhou's CStone Pharma filed for a Hong Kong IPO to develop its portfolio of 14 oncology candidates including PD-1, PD-L1 and CTLA-4 antibodies; LG Chem Life Sciences of South Korea formed a nearly $1 billion three-candidate IO collaboration with Cue Biopharma, a Boston area IO company; Agilent Technologies closed its $250 million acquisition of ACEA Biosciences, a San ...

Friday 16th November 2018

Tweets by @pharma_BI and @AVIVA1950 for The 14th Annual Personalized Medicine Conference: The Business of Personalization, November 15, 2018, HMS, Boston

Tweets by @pharma_BI and @AVIVA1950 for The 14th Annual Personalized Medicine Conference: The Business of Personalization, November 15, 2018, HMS, Boston Tweeter and Real Time Conference Press Coverage: Aviva Lev-Ari, PhD, RN 1. Retweet Like View Tweet activity Aviva Lev-Ari‏ @AVIVA1950 22h22 hours ago More #PMConf LIVE eProceeding Day Two – The 14th Annual Personalized Medicine Conferen...

Bridging The Gap: Cyclenium Pharma

Emerging Company Profile: Cyclenium Pharma spoke with Scrip about macrocyclic drug discovery, which covers the molecular space between traditional small...   

Civitas Solutions, Inc. Strategy, SWOT and Corporate Finance Report [Report Updated: 12102018] Prices from USD $175

Civitas Solutions, Inc. Strategy, SWOT and Corporate Finance ReportSummaryCivitas Solutions, Inc. Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360 view of the company.Key HighlightsCivitas Solutions, Inc. ...

Boston Scientific plans 3-year restructuring program

Boston Scientific is planning a restructuring program from 2019 to 2021 and to cut operating annual expenses by up to $150 mi -More- 

Thursday 15th November 2018

STAT Plus: This Boston #biotech wants to make it possible to take just one pill a week for conditions as varied as Alzheimer’s, addiction, allergies, malaria, schizophrenia, high cholesterol, and HIV. https://buff.ly/2PuPSBT 

STAT Plus: This Boston #biotech wants to make it possible to take just one pill a week for conditions as varied as Alzheimer’s, addiction, allergies, malaria, schizophrenia, high cholesterol, and HIV. https://buff.ly/2PuPSBT 

Neon Therapeutics Named a Top Place to Work in Massachusetts by The Boston Globe

CAMBRIDGE, Mass., Nov. 16, 2018 (GLOBE NEWSWIRE) -- Neon Therapeutics (Nasdaq: NTGN) has been named one of the top places to work in Massachusetts by The Boston Globe, an honor awarded based on employee feedback. The Top Places to Work awards recognize the most admired workplaces in the state, as voted on by the employees of those companies. The annual survey, now in its 11th year, measures e...

From the ashes of a failed pain drug, a new therapeutic path emerges

(Boston Children's Hospital) A surprising discovery about a failed pain drug -- and specifically, the pathway it targets, BH4 -- could have implications for autoimmunity and cancer. Neuroscientists at Boston Children's Hospital and immunologists from IMBA in Vienna report that BH4 also functions as a kind of immunological thermostat, raising and lowering the activity levels of T cells. Inhibiting ...

Azima posts reliability scores for industrial pump manufacturers.

BOSTON, Nov. 15, 2018 /PRNewswire/ -- Azima, Inc. has released the 2018 edition of its definitive reliability scores for the industrial pumps most commonly deployed Read more...

LIVE eProceeding Day Two – The 14th Annual Personalized Medicine Conference: The Business of Personalization, November 15, 2018, HMS, Boston

LIVE eProceeding Day Two – The 14th Annual Personalized Medicine Conference: The Business of Personalization, November 15, 2018, HMS, Boston Real Time Coverage: Aviva Lev-Ari, PhD, RN   PART II   The Business of Personalization “The successful implementation of [personalized medicine] will depend on the embrace of [its] principles in the business community.” — RAJU KUCHERLA...

LIVE eProceedings Day Two – The 14th Annual Personalized Medicine Conference: The Business of Personalization, November 15, 2018, HMS, Boston

LIVE eProceedings Day Two – The 14th Annual Personalized Medicine Conference: The Business of Personalization, November 15, 2018, HMS, Boston Real Time Coverage: Aviva Lev-Ari, PhD, RN   PART II   The Business of Personalization “The successful implementation of [personalized medicine] will depend on the embrace of [its] principles in the business community.” — RAJU KUCHERL...

PerkinElmer to Present at Evercore ISI HealthCONx Conference

PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that the Company will present at the 2018 Evercore ISI HealthCONx Conference on Thursday, November 29, at 10:15 a.m. ET at the Boston Harbor Hotel. Robert F. Friel, PerkinElmer’s chairman and chief executive officer, will provide ...

Centrexion Therapeutics changes its mind on initial public offering

The Boston-based company said it would not pursue a planned IPO, citing “market conditions.” Nasdaq had agreed to its listing on Tuesday.


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks